4 news items
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
REGN
23 May 24
other to further our shared goals. Together, we are united in the mission to serve as a beacon of transformation in cancer care. About
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
.
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
.
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture
- Prev
- 1
- Next